Navigation Links
KineMatik Group Ltd. Appoints Michael G. Jarjour as President & CEO
Date:1/21/2009

Former Organon VP of Global Marketing Will Oversee Life Sciences Software Group

Cork, Ireland (PRWEB) January 21, 2009 - The KineMatik™ Group LTD ("KineMatik"), providers of software solutions for managing scientific R&D knowledge, information and processes, announced that it has appointed Michael G. Jarjour as President & CEO.

Mr. Jarjour, with more than eighteen years of experience in the pharmaceutical research and healthcare technology industries, will lead KineMatik as the company continues to offer leadership and innovation to its pharmaceutical, biotechnology and government clients.

"We are delighted to welcome Michael to the KineMatik team. His extensive experience in sales, marketing, operations and strategic planning, combined with his background and entrepreneurial skills in the life sciences and technology industries, will help us consolidate our position as leaders in the scientific enterprise content of management space," said Harry Lorton, Chairman of the Board of Directors for KineMatik.

"I am pleased to join KineMatik, which has developed an impressive and innovative technology platform," said Mr. Jarjour. "Serving industries so dependent on the rapid, accurate collection of scientific data, KineMatik offers a unique value proposition by supporting secure portfolio, knowledge and project management while lowering costs, increasing productivity and improving time-to-market. In this era of financial and regulatory scrutiny, and intellectual property protection, KineMatik is poised to make a difference in the research and development process."

Before joining KineMatik, Mr. Jarjour was Vice President of Global Marketing for Organon, responsible for leading the $1.5 billion gynecology and urology franchise.

Previously, Mr. Jarjour held key positions at top tier pharmaceutical organizations including Bristol-Myers Squibb, Pharmacia, Warner Lambert and Wyeth. Prior to his work in the pharmaceutical industry, he was the COO and founder of a healthcare technology enterprise for an award-winning, best-in-industry wireless Internet prescribing platform.

Mr. Jarjour holds a BS in Finance from Florida International University and an MBA from the Rutgers University.

About KineMatik: KineMatik brings business methods to the life sciences R&D process, by increasing productivity, accountability and transparency. The company's flagship product, eNovator, is the only software program that lets pharmaceutical, biotechnology and government organizations collaboratively manage their information, knowledge and business processes in one seamlessly integrated and secure system. eNovator, allows researchers to deliver innovation throughout the R&D product development lifecycle. Established in Cork, Ireland in 1999, KineMatik also has offices in London, Princeton, and San Diego. Additional information is available at www.kinematik.com.

Contact:
Jennifer Buchholz
KineMatik
jbuchholz(at)kinematik(dot)com

# # #

Read the full story at http://www.prweb.com/releases/KineMatik_Group/Michael_G_Jarjour/prweb1889204.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. AIM Health Group Inc. and Med-Emerg International Inc. Announce Completion of Previously Disclosed Merger Transaction
2. The Quantum Group Announces Support of Technology Bill Before Congress
3. KJT Group L.L.C. Continues Solid Growth
4. Atlanta Educator Kim Bearden Honored as Healthy Hero by AMERIGROUP Foundation
5. Rochester Medical Announces Settlement With TYCO Healthcare Group, L.P., Now Operating as Covidien Ltd.
6. EBG Advisors and Oldaker Group Form National Health Advisors
7. The Quantum Group and IBM Announce Hosting Agreement for Advanced Healthcare Solutions
8. SOKO Fitness & Spa Group Announces Second Quarter FY2009 Financial Results
9. SOKO Fitness & Spa Group Announces Changes to Previously Issued Financial Statements
10. U.S. and European Advocacy Groups Launch United, Global Campaign to Prevent Cervical Cancer
11. Med-Emerg International Inc. receives court approval for AIM Health Group arrangement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2017)... (PRWEB) , ... May 29, 2017 , ... ... reliable than residential locks. This is because businesses don’t just need to protect ... have to protect against theft of personal information, physical inventory, assets and company ...
(Date:5/28/2017)... , ... May 28, 2017 , ... HYPERAMS, LLC ... medical scrubs and uniform distributor based in Lima, Ohio. The sale began this week ... one million units of medical garments, scrubs, uniforms, and medical accessories, including blood pressure ...
(Date:5/27/2017)... ... ... the dentist? You should go twice per year for checkups, but if you want to ... are some dental tips to help out: , 1. Brushing Teeth - Brush your teeth ... a locker at school for a quick brushing after lunch. Use a small brush head ...
(Date:5/26/2017)... YORK, NY (PRWEB) , ... May 26, 2017 ... ... Board (SAB) met this week to review more than eighty-nine grant submissions ... experienced and emerging young scientists in the Parkinson’s field.     , The American Parkinson ...
(Date:5/26/2017)... MN (PRWEB) , ... May 26, 2017 , ... A ... U.S. states with the healthiest seniors are located in the Midwest. With the average ... more and more people are concerned with both the quality and affordability of where ...
Breaking Medicine News(10 mins):
(Date:5/26/2017)... May 25, 2017  In response to the opioid ... Direct Relief is working with Pfizer to make up ... no cost to community health centers, free and charitable ... "Pfizer has a long-standing commitment to ... ensuring patient safety through educational activities," said Caroline ...
(Date:5/22/2017)... , May 22, 2017  Lilac Corp, the ... announces the launch of a new website ... results of a clinical study that showed surprising ... with Gene-Eden-VIR/Novirin in individuals suffering from HPV warts, ... that there are no other treatments that clear ...
(Date:5/18/2017)... N.J. , May 17, 2017  Bayer announced ... oncology portfolio will be presented at the 53 rd ... Oncology (ASCO), taking place June 2-6 in ... presented at ASCO span prostate, colorectal, liver and thyroid ... analysis from the Phase II CHRONOS-1 trial of copanlisib ...
Breaking Medicine Technology: